<?xml version="1.0" encoding="iso-8859-1"?>
<legaldoc>
<law type="statute">
<section>
<amendatorysection amended="yes" chaptername="Public Health And Welfare" statutenumber="71-2421"><bookinfo>Revised Statutes Cumulative Supplement, 2014</bookinfo><statuteno>71-2421</statuteno><catchline>Collection or return of dispensed
drugs and devices; conditions;
fee; liability; professional disciplinary action.</catchline>
<para>(1) To protect the public safety, dispensed drugs or devices:</para>
<para>(a) May be collected in a pharmacy for disposal;</para>
<para>(b) May be returned to a pharmacy in response
to a recall by the manufacturer, packager, or distributor or if a device is
defective or malfunctioning;</para>
<para>(c) Shall not be returned
to saleable inventory nor made available for subsequent relabeling and redispensing,
except as provided in subdivision (1)(d) of this section; or</para>
<para>(d) May be returned from a long-term care
facility to the pharmacy from which they were dispensed for credit or for
relabeling and redispensing, except that:</para>
<para>(i) No controlled substance may be returned;</para>
<para>(ii) The decision to accept the return of the dispensed drug or device
shall rest solely with the pharmacist;</para>
<para>(iii) The dispensed drug or device shall have been in the control of
the long-term care facility at all times;</para>
<para>(iv) The dispensed drug or device shall be in the original and unopened
labeled container with a tamper-evident seal intact, as dispensed by the pharmacist. Such container shall bear the expiration
date or calculated expiration date and lot number; and</para>
<para>(v) Tablets or capsules shall have been dispensed in a unit dose container
which is impermeable to moisture and approved by the Board of Pharmacy.</para>
<para>(2) Pharmacies may charge
a fee for collecting dispensed drugs or devices for disposal or from a long-term
care facility for credit or for relabeling and redispensing.</para>
<para>(3) Any person or entity
which exercises reasonable care in collecting dispensed drugs or devices for
disposal or from a long-term care facility for credit or for relabeling and
redispensing pursuant to this section shall be immune from civil or criminal
liability or professional disciplinary action of any kind for any injury,
death, or loss to person or property relating to such activities.</para>
<para>(4) A drug manufacturer
which exercises reasonable care shall be immune from civil or criminal liability
for any injury, death, or loss to persons or property relating to the relabeling
and redispensing of drugs returned from a long-term care facility.</para>
<para>(5) Notwithstanding subsection
(4) of this section, the relabeling and redispensing of drugs returned from
a long-term care facility does not absolve a drug manufacturer of any criminal
or civil liability that would have existed but for the relabeling and redispensing
and such relabeling and redispensing does not increase the liability of such
drug manufacturer that would have existed but for the relabeling and redispensing.</para>
<para>(6) For purposes of this section:</para>
<para>(a) Calculated expiration date means the expiration date on the manufacturer's,
packager's, or distributor's container or one year from the date the drug
or device is repackaged, whichever is earlier;</para>
<para>(b) Dispense, drugs, and devices are defined in the Pharmacy Practice
Act; and</para>
<para>(c) Long-term care facility does not include an assisted-living facility
as defined in section 71-406.</para>
</amendatorysection></section><source><para>Laws 1999, LB 333, &#167; 1; </para><para>Laws 2001, LB 398, &#167; 74; </para><para>Laws 2002, LB 1062, &#167; 53; </para><para>Laws 2007, LB247, &#167; 51; </para><para>Laws 2007, LB463, &#167; 1199; </para><para>Laws 2011, LB274, &#167; 1.</para></source><crossreference><para><emphasis>Pharmacy Practice Act,</emphasis> see section 38-2801.</para></crossreference>  </law>
</legaldoc>
